Cancer stem cells - the current status of an old concept: literature review and clinical approaches

被引:40
作者
Fulawka, Lukasz [1 ,2 ]
Donizy, Piotr [1 ]
Halon, Agnieszka [1 ]
机构
[1] Wroclaw Med Univ, Dept Pathomorphol & Oncol Cytol, PL-50556 Wroclaw, Poland
[2] Lower Silesian Oncol Ctr, Dept Pathomorphol, PL-53413 Wroclaw, Poland
关键词
Cancer stem cells; Stem cells; Tumour-initiating cells; Tumour-propagating cells; Carcinogenesis; Tumour heterogeneity; Clonal evolution; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; PROSPECTIVE IDENTIFICATION; DRUG-RESISTANCE; HETEROGENEITY; TRANSPLANTATION; EXPRESSION; PREDICTOR; MARKER; TUMORS;
D O I
10.1186/0717-6287-47-66
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
As regards their morphology and biology, tumours consist of heterogeneous cell populations. The cancer stem cell (CSC) hypothesis assumes that a tumour is hierarchically organized and not all of the cells are equally capable of generating descendants, similarly to normal tissue. The only cells being able to self-renew and produce a heterogeneous tumour cell population are cancer stem cells. CSCs probably derive from normal stem cells, although progenitor cells may be taken into consideration as the source of cancer stem cells. CSCs reside in the niche defined as the microenvironment formed by stromal cells, vasculature and extracellular matrix. The CSC assays include FACS sorting, xenotransplantation to immunodeficient mice (SCID), incubation with Hoechst 33342 dye, cell culture in non-adherent conditions, cell culture with bromodeoxyuridine. CSCs have certain properties that make them resistant to anticancer therapy, which suggests they may be the target for potential therapeutic strategies.
引用
收藏
页数:9
相关论文
共 59 条
[1]  
Ahmed A.U., 2011, CANC STEM CELLS CUTT, P375
[2]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[3]  
Azmi AS, 2011, CANC STEM CELLS CUTT, P135
[4]   Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis [J].
Battula, Venkata Lokesh ;
Shi, Yuexi ;
Evans, Kurt W. ;
Wang, Rui-Yu ;
Spaeth, Erika L. ;
Jacamo, Rodrigo O. ;
Guerra, Rudy ;
Sahin, Aysegul A. ;
Marini, Frank C. ;
Hortobagyi, Gabriel ;
Mani, Sendurai A. ;
Andreeff, Michael .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (06) :2066-2078
[5]   Unravelling cancer stem cell potential [J].
Beck, Benjamin ;
Blanpain, Cedric .
NATURE REVIEWS CANCER, 2013, 13 (10) :727-738
[6]   CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors [J].
Beier, Dagmar ;
Wischhusen, Joerg ;
Dietmaier, Wolfgang ;
Hau, Peter ;
Proescholdt, Martin ;
Brawanski, Alexander ;
Bogdahn, Ulrich ;
Beier, Christoph P. .
BRAIN PATHOLOGY, 2008, 18 (03) :370-377
[7]   CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles [J].
Beier, Dagmar ;
Hau, Peter ;
Proescholdt, Martin ;
Lohmeier, Annette ;
Wischhusen, Joerg ;
Oefner, Peter J. ;
Aigner, Ludwig ;
Brawanski, Alexander ;
Bogdahn, Ulrich ;
Beier, Christoph P. .
CANCER RESEARCH, 2007, 67 (09) :4010-4015
[8]   Sheep, wolf, or werewolf: Cancer stem cells and the epithelial-to-mesenchymal transition [J].
Chang, Jeffrey T. ;
Mani, Sendurai A. .
CANCER LETTERS, 2013, 341 (01) :16-23
[9]   Stem cells and cancer: Two faces of eve [J].
Clarke, MF ;
Fuller, M .
CELL, 2006, 124 (06) :1111-1115
[10]  
Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126